OssDsign AB
STO:OSSD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6
10.88
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one OSSD stock under the Base Case scenario is 10.35 SEK. Compared to the current market price of 7.2 SEK, OssDsign AB is Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
OssDsign AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for OSSD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
OssDsign AB
Balance Sheet Decomposition
OssDsign AB
Current Assets | 155m |
Cash & Short-Term Investments | 118.8m |
Receivables | 21.9m |
Other Current Assets | 14.3m |
Non-Current Assets | 151.4m |
Long-Term Investments | 152k |
PP&E | 2.1m |
Intangibles | 149.1m |
Current Liabilities | 24.5m |
Accounts Payable | 6.5m |
Accrued Liabilities | 15.8m |
Other Current Liabilities | 2.2m |
Non-Current Liabilities | 57.1m |
Long-Term Debt | 1.3m |
Other Non-Current Liabilities | 55.8m |
Earnings Waterfall
OssDsign AB
Revenue
|
123.5m
SEK
|
Cost of Revenue
|
-19.8m
SEK
|
Gross Profit
|
103.6m
SEK
|
Operating Expenses
|
-178m
SEK
|
Operating Income
|
-74.3m
SEK
|
Other Expenses
|
-39.5m
SEK
|
Net Income
|
-113.8m
SEK
|
Free Cash Flow Analysis
OssDsign AB
SEK | |
Free Cash Flow | SEK |
In Q2 2024, OssDsign celebrated a significant milestone, achieving over SEK 100 million in 12-month rolling orthobiologics sales, marking a rapid growth from its initial sales two years ago. The company also treated over 5,000 patients with OssDsign Catalyst. U.S. sales saw triple-digit growth for the ninth consecutive quarter. Financially, OssDsign reported Q2 sales of SEK 29.7 million, a 143% increase from the previous year, and a gross margin of 93.2%. Looking forward, the company aims to expand its U.S. market presence, develop new products, and build more robust clinical data to drive future growth.
What is Earnings Call?
OSSD Profitability Score
Profitability Due Diligence
OssDsign AB's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
OssDsign AB's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
OSSD Solvency Score
Solvency Due Diligence
OssDsign AB's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
OssDsign AB's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OSSD Price Targets Summary
OssDsign AB
According to Wall Street analysts, the average 1-year price target for OSSD is 14.28 SEK with a low forecast of 14.14 SEK and a high forecast of 14.7 SEK.
Dividends
Current shareholder yield for OSSD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
OSSD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Contact
IPO
Employees
Officers
The intrinsic value of one OSSD stock under the Base Case scenario is 10.35 SEK.
Compared to the current market price of 7.2 SEK, OssDsign AB is Undervalued by 30%.